Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues |
| Vycor Medical | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.5 |
| NovaVision | | | 0.0 | | | | 0.0 | |
| Nova Vision | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | | 0.0 |
| |
| EBIT |
| Vycor Medical | 0.2 | 0.1 | | 0.1 | 0.1 | | | |
| Nova Vision | -0.1 | 0.0 | | 0.0 | -0.1 | | | |
| Corporate Segment | 0.0 | 0.0 | | 0.1 | -0.1 | | | |
| |
| Mix |
| Vycor Medical | 96.0% | 93.3% | 93.5% | 91.1% | 91.6% | 90.2% | 90.8% | 94.1% |
| NovaVision | | | 6.5% | | | | 9.2% | |
| Nova Vision | 4.0% | 6.7% | | 8.9% | 8.4% | 9.8% | | 5.9% |
| |
| Growth |
| Vycor Medical | 55.1% | 17.2% | -3.9% | -35.4% | 9.4% | -5.9% | 20.3% | 111.1% |
| NovaVision | | | -33.7% | | | | | |
| Nova Vision | -33.4% | -8.9% | | 0.3% | -19.9% | -7.9% | | |
|